Evidence map›Paper›PMID 38923425›Full record

ArticleJournal of radiation research2024

Quality of palliative radiotherapy assessed using quality indicators: a multicenter survey†.

Tetsuo Saito, Naoto Shikama, Takeo Takahashi, Naoki Nakamura, Takashi Mori, Kaori Nakajima, Masahiko Koizumi, Shuhei Sekii, Takeshi Ebara, Hiroki Kiyohara and 20 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of radiation research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Tetsuo SaitoDivision of Integrative Medical Oncology, Saiseikai Kumamoto Hospital, 5-3-1 Chikami, Minami-ku, Kumamoto-Shi, Kumamoto 861-4193, Japan.
Naoto ShikamaDepartment of Radiation Oncology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Takeo TakahashiDepartment of Radiation Oncology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe-shi, Saitama 350-8550, Japan.
Naoki NakamuraDepartment of Radiation Oncology, St. Marianna University Hospital, 2-16-1 Sugao, Miyamae, Kawasaki-shi, Kanagawa 216-8511, Japan.
Takashi MoriDepartment of Radiation Oncology, Hokkaido University Hospital, Kita 14 Nishi 5, Kita-ku, Sapporo-shi, Hokkaido 060-8638, Japan.
Kaori NakajimaDepartment of Radiology, Asahikawa Medical University, 2-1 Midorigaoka-Higashi, Asahikawa-shi, Hokkaido 078-8510, Japan.
Masahiko KoizumiRadiation Oncology Laboratory, Department of Medical Physics & Engineering, Graduate School of Medicine and Health Science, Osaka University, 1-7 Yamadaoka, Suita-shi, Osaka 565-0871, Japan.
Shuhei SekiiDepartment of Radiation Oncology, Kita-Harima Medical Center, 926-250 Ichibacho, Ono-shi, Hyogo 675-1392, Japan.
Takeshi EbaraDepartment of Radiation Oncology, Kyorin University, School of Medicine, 6-20-2 Shinkawa Mitaka-shi, Tokyo 181-8611, Japan.
Hiroki KiyoharaDepartment of Radiation Oncology, Japanese Red Cross Maebashi Hospital, 389-1 Asakura-Machi, Maebashi-shi, Gunma 371-0811, Japan.
Keiko HiguchiDepartment of Radiation Oncology, Isesaki Municipal Hospital, 12-1 Tsunatorihon-machi, Isesaki-Shi, Gunma 372-0817, Japan.
Atsunori YorozuDepartment of Radiation Oncology, NHO Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro-ku, Tokyo 152-8902, Japan.
Takeshi NishimuraDepartment of Radiation Oncology, Japanese Red Cross Society Kyoto Daiichi Hospital, 15-749 Honmachi, Higashiyama-ku, Kyoto-Shi, Kyoto 605-0981, Japan.
Yasuo EjimaDepartment of Radiology, Dokkyo Medical University, 880 Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi 321-0293  Japan.
Hideyuki HaradaRadiation and Proton Therapy Center, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8777, Japan.
Norio ArakiDepartment of Radiation Oncology, NHO Kyoto Medical Center, 1-1 Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto-shi, Kyoto 612-8555, Japan.
Misako MiwaDepartment of Radiation Oncology, Sendai Kousei Hospital, 1-20 Sutsumidori, Amemiya, Aoba-ku, Sendai-shi, Miyagi 981-0914, Japan.
Kazunari YamadaDepartment of Radiation Oncology, Seirei Mikatahara General Hospital, 3453 Mikatahara, Chuo-ku, Hamamatsu-shi, Shizuoka 433-8558, Japan.
Terufumi KawamotoDepartment of Radiation Oncology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Nobuki ImanoDepartment of Radiation Oncology, Graduate School of Biomedical Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima-shi, Hiroshima 734-8551, Japan.
Joichi HeiannaDepartment of Radiation Oncology, Nanbu Tokushukai Hospital, 171-1 Hokama, Yaese-cho, Shimajiri-gun, Okinawa 901-0493, Japan.
Miwako NozakiDepartment of Radiation Oncology, Dokkyo Medical University Saitama Medical Center, 2-1-50 Minamikoshigaya, Koshigaya-shi, Saitama 343-8555, Japan.
Yuki WadaDepartment of Radiology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita-shi, Akita 010-8543, Japan.
Yu OhkuboDepartment of Radiation Oncology, Saku Central Hospital Advanced Care Center, 3400-28 Nakagomi, Saku-shi, Nagano 385-0051, Japan.
Nobue UchidaDepartment of Radiation Oncology, Kawasaki Municipal Ida Hospital, 2-27-1 Ida, Nakahara-ku, Kawasaki,-shi, Kanagawa 211-0035, Japan.
Miho WatanabeDiagnostic Radiology and Radiation Oncology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba-shi, Chiba 260-8670, Japan.
Takashi KosugiDepartment of Radiation Oncology, Fujieda Municipal General Hospital, 4-1-11 Surugadai, Fujieda-shi, Shizuoka 426-8677, Japan.
Kazunari MiyazawaDepartment of Radiolgy, Showa General Hospital, 8-1-1 Hanakoganei, Kodaira-shi, Tokyo 187-8510, Japan.
Shigeo YasudaDepartment of Radiology, Chiba Rosai Hospital, 2-16 Tatsumidai-higashi, Ichihara-shi, Chiba 290-0003, Japan.
Hiroshi OnishiDepartment of Radiology, University of Yamanashi, 1110 Shimokato, Chuo-shi, Yamanashi 409-3898, Japan.

Funding

Health Labor Sciences ResearchMinistry of Health, Labor, and Welfare of Japan JPMH21EA1010
6 · The paper itself

Abstract

We sought to identify potential evidence-practice gaps in palliative radiotherapy using quality indicators (QIs), previously developed using a modified Delphi method. Seven QIs were used to assess the quality of radiotherapy for bone metastases (BoM) and brain metastases (BrM). Compliance rate was calculated as the percentage of patients for whom recommended medical care was conducted. Random effects models were used to estimate the pooled compliance rates. Of the 39 invited radiation oncologists, 29 (74%) from 29 centers participated in the survey; 13 (45%) were academic and 16 (55%) were non-academic hospitals. For the QIs, except for BoM-4, the pooled compliance rates were higher than 80%; however, for at least some of the centers, the compliance rate was lower than these pooled rates. For BoM-4 regarding steroid use concurrent with radiotherapy for malignant spinal cord compression, the pooled compliance rate was as low as 32%. For BoM-1 regarding the choice of radiation schedule, the compliance rate was higher in academic hospitals than in non-academic hospitals (P = 0.021). For BrM-3 regarding the initiation of radiotherapy without delay, the compliance rate was lower in academic hospitals than in non-academic hospitals (P = 0.016). In conclusion, overall, compliance rates were high; however, for many QIs, practice remains to be improved in at least some centers. Steroids are infrequently used concurrently with radiotherapy for malignant spinal cord compression.

Indexed as

Palliative CareQuality Indicators, Health CareBone NeoplasmsBrain NeoplasmsGuideline AdherenceHumansRadiotherapySurveys and Questionnairesbone metastasesbrain metastasesevidence-practice gapmalignant spinal cord compressionpalliative radiotherapyquality indicator

Identifiers

PMID38923425
PMCPMC11262857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.